The news: The Supreme Court upheld nationwide access to telehealth prescribing and mail delivery of the abortion drug mifepristone, blocking a Louisiana circuit court ruling that would have limited access to in-person visits only.

Why it matters: Recent data suggests that telehealth and medication access are the primary drivers of rising abortion rates post-Roe.

• Total volume of procedures increased significantly: There were almost 1.13 million clinician-provided abortions last year, up 21% from 930,160 in 2020, per Guttmacher Institute data.
• Telehealth is now a pillar of abortion access: About 27% of abortions in 2025 were provided via telehealth, according to the Society of Family Planning. More than half (56%) were provided under shield laws that protect clinicians treating patients in states with abortion bans or restrictions.
• Medication is the preferred method: Nearly two-thirds (63%) of US abortions were medication abortions in 2023, up from 53% n 2020, per Guttmacher.

Implications for telehealth providers: The decision preserves telehealth-enabled abortion access for now, but legal challenges are likely to continue as states remain deeply divided on abortion access. Currently, 25 states and Washington DC allow telehealth abortions, while 13 have near-total abortion bans, with nine specifically prohibiting telehealth medication abortions.

The case also underscores how telehealth has become core healthcare infrastructure rather than just an added convenience. Shield laws and remote prescribing have expanded cross-state access and reshaped how patients obtain care. While the ruling is specific to abortion, it could shape broader debates over telehealth prescribing. Telehealth prescribing rules expanded during the pandemic, greatly increasing remote prescription drug access, and many virtual care providers now rely on those rules remaining in place.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.